SOLID-PHASE EXTRACTION FOLLOWED BY DISPERSIVE LIQUID-LIQUID MICROEXTRACTION FOR THE SENSITIVE DETERMINATION OF ECSTASY COMPOUNDS AND AMPHETAMINES IN BIOLOGICAL SAMPLES

A novel approach for the determination of ecstasy and amphetamines (3,4-methylenedioxymethylamphetamine (MDMA, Ecstasy), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxyethylamphetamine (MDEA) and 3,4-methylenedioxypropylamphetamine (MDPA)) in biological samples is presented. The analytes were extracted from the matrix and transferred to a small volume of a high density, water insoluble solvent using solid-phase extraction (SPE) followed by dispersive liquid-liquid microextraction (DLLME). This combination not only resulted in a high enrichment factor, but also it could be used in complex matrices (biological samples). Some important extraction parameters, such as sample solution flow rate, sample pH, type and volume of extraction and disperser solvents as well as the salt addition, were studied and optimized. Under the optimized conditions, the calibration graphs were linear in the range of 0.5-500 mu g L-1 and 1.0-500 mu g L-1 with detection limits in the range of 0.1-0.3 mu g L-1 and 0.2-0.7 mu g L-1 in urine and plasma samples, respectively. The results showed that SPE-DLLME is a suitable method for the determination of ecstasy components and amphetamines in biological and water samples.